Gapping up
In reaction to earnings/guidance:
- CMTL +2.1%, MU +1.5%
Other news:
- AMLX +9.3% (receives FDA approval for Relyvrio)
- RC +4.9% (increases share buyback authorization by $25 mln)
- APRN +2.5% (CFO to resign)
- FLR +2.3% (US Dept of Energy extends Fluor-led Savannah River contract)
- IMRX +1.6% (receives FDA clearance of IND application for Phase 1/2a Clinical Trial of IMM-1-104)
- TSE +1.4% (considering closing its styrene monomer production site in Germany)
- KGC +1.1% (Toronto Stock Exchange accepts notice to increase max shares KGC can repurchase)
- BMRN +1% (resubmits BLA to FDA for its investigational AAV gene therapy)
- PLTK +1% (provides update on shares tendered to date in its tender offer for its common stock)
Analyst comments:
- NOV +1.8% (upgraded to Buy from Neutral at BofA Securities)
- CBOE +1.2% (upgraded to Neutral from Sell at Goldman)
